Acumen Pharmaceuticals raises $160m for IPO

Acumen Pharmaceuticals Inc, a biopharmaceutical company, has raised $160 million for its IPO.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this